Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
This study evaluated the economic impact of patient-focused pharmacist intervention in the community retail setting in patients with hypertension, diabetes, asthma, and/or hypercholesterolemia. Specially trained pharmacists intervened by providing targeted patient education, performing systematic patient monitoring, offering feedback and behavior modification, and communicating regularly with patients' physicians to enable early intervention for drug-related problems. We evaluated prescription drug costs and total medical costs by comparing claims data from 188 patients enrolled in the program at three intervention pharmacies with data from 401 control patients at five nonparticipating pharmacies from the same retail chain. For all disease states, the average cost per prescription was significantly higher in the group receiving intervention than in the control group. Differences in total monthly prescription costs were significant only for patients with asthma, with higher monthly costs in the group receiving intervention. Substantial savings were demonstrated across all cost analyses for total monthly medical costs. Savings ranged from a conservative estimate of $143.95 per patient per month to $293.39 per patient per month when accounting for the possible influence of age, comorbid conditions, and disease severity. Our data indicate that pharmacist intervention in this community pharmacy-based disease management model substantially reduced monthly health care costs in patients with hypertension, hypercholesterolemia, diabetes, and asthma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“educational meetings (n = 2; 16%) [54,69]”
From Systematic review of knowledge translation strategies in the allied health professions (2012) · cites this paper as [69]
In the citing paper
“pharmacy (n = 3; 25% of pharmacy studies) [51,54,69]”
From Systematic review of knowledge translation strategies in the allied health professions (2012) · cites this paper as [69]
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Guidelines for the diagnosis and management of asthma.
Solomon, P. A. (1992) · PubMed · Cited by 2,004
Drug-Related Morbidity and Mortality: A Cost-of-Illness Model
Johnson, J. A. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430180043006 · Cited by 616
Comprehensive Pharmaceutical Care in the Chain Setting
Park, J. J., Kelly, P. J., Carter, B. L., & Burgess, P. P. (1996) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30099-7 · Cited by 155
Value of Community Pharmacists' Interventions to Correct Prescribing Errors
Rupp, M. T. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202601218 · Cited by 122
KIMBERLIN, C. L., BERARDO, D. H., PENDERGAST, J. F., & MCKENZIE, L. C. (1993) · Medical Care · doi:10.1097/00005650-199305000-00007 · Cited by 60
Cholesterol-Reduction Intervention Study (CRIS)
Oster, G. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440070051006 · Cited by 48
Evaluation of clinical pharmacist consultations in a family practice office
Brown, D. J., Helling, D. K., & Jones, M. E. (1979) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/36.7.912 · Cited by 43
McCombs, J. S., Cody, M., Besinque, K., Borok, G. M., Ershoff, D. H., Groshen, S. G., Hay, J. W., Johnson, K. A., Nichol, M. B., & Nye, M. T. (1995) · Clinical Therapeutics · doi:10.1016/0149-2918(95)80097-2 · Cited by 21
Clinical Monitoring Plans for the Delivery of Pharmaceutical Care
Munroe, W. P. (1996) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30082-1 · Cited by 4
Self-citation
Cited by
Audit and feedback: effects on professional practice and healthcare outcomes
Ivers, N., Jamtvedt, G., Flottorp, S., Young, J. M., Odgaard-Jensen, J., French, S. D., O'Brien, M. A., Johansen, M., Grimshaw, J., & Oxman, A. D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000259.pub3 · Cited by 5,485
Improving Primary Care for Patients With Chronic Illness
Bodenheimer, T. (2002) · JAMA · doi:10.1001/jama.288.14.1775 · Cited by 2,961
Improving Primary Care for Patients With Chronic Illness: The Chronic Care Model, Part 2
Bodenheimer, T., Wagner, E. H., & Grumbach, K. (2002) · JAMA · doi:10.1001/jama.288.15.1909 · Cited by 2,413
“Compared with that for a control group, total health care costs dropped for diabetic patients enrolled in a program in which specially trained pharmacists provided patient education, monitoring, and feedback to physicians.(31) Diabetic patients in rural Austria participating in a structured education and treatment pro…”
BackgroundAudit and feedback: effects on professional practice and health care outcomes
Jamtvedt, G., Young, J. M., Kristoffersen, D. T., O'Brien, M. A., & Oxman, A. D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000259.pub2 · Cited by 912
Machado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k311 · Cited by 378
Metadata
- Authors
- Munroe, W.
- Corresponding author
- Munroe, W
- Venue
- Clinical Therapeutics
- Publisher
- Elsevier BV
- Published
- 1997-02
- Volume
- 19
- Issue
- 1
- Pages
- 113-123
- ISSN
- 0149-2918 (ISSN-L)
- OpenAlex
- W1977985659
- Cited by
- 122
- References
- 10
- Citations by year
- 2023: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 4 · 2015: 4 · 2014: 2 · 2013: 3 · 2012: 7
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Clinical Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- pharmacist intervention, community pharmacy, disease management, cost reduction, prescription drug costs, health care costs, hypertension, diabetes mellitus, asthma, hypercholesterolemia, patient education, drug-related problems, therapeutic drug monitoring, behavior modification, physician communication
- MeSH terms
- Aged, Community Pharmacy Services, Female, Humans, Male, Middle Aged, Patient Education as Topic, Prescription Fees, Health Care Costs, Economics, Pharmaceutical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. https://app.cochat.ai/papers/10.1016/s0149-2918(97)80078-1
- The paper
- Munroe, W. (1997). Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clinical Therapeutics. https://doi.org/10.1016/s0149-2918(97)80078-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.